Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Stuart Marcus, MD, PhD
DUSA Pharmaceuticals, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Therapeutics Clinical Research
San Diego, California, United States
- Altman Dermatology Associates
Arlington Heights, Illinois, United States
- Shideler Clinical Research Center
Carmel, Indiana, United States
- the Indiana Clinical Trials Center, Pc
Plainfield, Indiana, United States
- Minnesota Clinical Study Center
Fridley, Minnesota, United States
- Dermresearch, Inc.
Austin, Texas, United States
- Virginia Clinical Research, Inc.
Norfolk, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2017
- Primary completion
- 30 Sept 2017
- Completion
- 31 Jan 2018
- Last update posted
- 7 Nov 2017
- Registered enrollment
- 0
- Registry id
- NCT03024060
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.